Intravenous delivery of hydrophobin-functionalized porous silicon nanoparticles: stability, plasma protein adsorption and biodistribution.
about
Microfluidic assembly of multistage porous silicon-lipid vesicles for controlled drug releaseThe impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug deliveryNanoparticle Uptake: The Phagocyte ProblemAmine-modified hyaluronic acid-functionalized porous silicon nanoparticles for targeting breast cancer tumors.Radiolabeling of Nanoparticles and Polymers for PET ImagingAntibody-functionalized porous silicon nanoparticles for vectorization of hydrophobic drugs.Applications of zero-valent silicon nanostructures in biomedicine.The fate of calcium carbonate nanoparticles administered by oral route: absorption and their interaction with biological matrices.Chondroitin sulfate functionalized mesostructured silica nanoparticles as biocompatible carriers for drug delivery.Protein bio-corona: critical issue in immune nanotoxicology.Biosafety and bioapplication of nanomaterials by designing protein-nanoparticle interactions.Functionalised porous silicon as a biosensor: emphasis on monitoring cells in vivo and in vitro.Recent advances in porous silicon technology for drug delivery.Two forms and two faces, multiple states and multiple uses: Properties and applications of the self-assembling fungal hydrophobins.The interaction of nanoparticles with plasma proteins and the consequent influence on nanoparticles behavior.Porous silicon nanoparticles for nanomedicine: preparation and biomedical applications.Applications of hydrophobins: current state and perspectives.Recent Advances in Fungal Hydrophobin Towards Using in Industry.Small interfering RNA delivery by polyethylenimine-functionalised porous silicon nanoparticles.Surface functionalization of carbon nanomaterials by self-assembling hydrophobin proteins.Cellular interactions of surface modified nanoporous silicon particles.Bioreducible Hydrophobin-Stabilized Supraparticles for Selective Intracellular Release.Plasma protein adsorption and biological identity of systemically administered nanoparticles.In-solution antibody harvesting with a plant-produced hydrophobin-Protein A fusion.Design of Highly Stable Echogenic Microbubbles through Controlled Assembly of Their Hydrophobin Shell.Functionalization of Mesoporous Silicon Nanoparticles for Targeting and Bioimaging PurposesDevelopment of Magnetic Nanoparticles for Cancer Gene Therapy: A Comprehensive Review
P2860
Q26851133-E4ECA96F-BB86-48E6-A9EC-9D228DCADB49Q28085280-8FF40FDF-1400-4CD0-8941-4A4393697708Q28395287-9FD8E917-9A2A-45CC-8318-1CBC0C497965Q30425859-B98754E0-6B10-4015-A20B-699D16942A31Q33584719-6FD4A782-16C1-49FC-9A56-7959996CC93AQ34314945-7A4F23CD-2D50-46F0-96A3-796C435C49A0Q34490443-92A0406F-58D5-4124-BA1D-AF73E0E19C44Q35223423-6E516A17-71F9-415B-A261-884D06BEC69CQ36318382-07573DB5-2EC9-4FFD-A268-82FC75D0FFD9Q37651354-ADF3F31C-D365-41E7-97CE-7A714CAA136EQ38076084-5A23D39D-9EC7-4AA7-AAAB-B118F854C946Q38109013-67BD0EC1-9238-4F29-9ECE-CE6F3F64E5D7Q38123855-6B56A98B-76A3-445B-A5AE-05EB5B50C4E5Q38126470-A40F0A9D-E373-4320-81EC-F3E13435BBAAQ38176391-46212612-8937-466F-8B20-9AE1B0A889A3Q38208617-6BB426FD-1766-48A2-A58F-56B94BAC5661Q38309346-BA9AD072-808B-4D7D-AA8E-4CF3281202ECQ38553683-7BEBD4C3-536C-407D-8EB4-4244531F846EQ38837543-FD35B06F-EAF0-4C1C-9D9F-62FE4E6B5A5BQ39253738-03EC08CA-0093-4742-9692-B0665FF137B2Q39363744-2C0DC82D-93E4-4A65-8261-2CF18DE1558DQ41662449-4DCA4649-ADCE-4C43-8545-60DF3FF9AA26Q47570893-926977DF-8067-4CF4-B8D1-411B25764F69Q47824698-940AC374-4C6C-49CB-BB31-075D2180C930Q48141332-D75B86B3-4473-47A9-A92F-7568F15B0017Q58910064-B713D293-CEEF-4405-B1DF-D4F8B9C2B311Q58998029-E531E222-815F-4252-93DA-315ADE7CE291
P2860
Intravenous delivery of hydrophobin-functionalized porous silicon nanoparticles: stability, plasma protein adsorption and biodistribution.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Intravenous delivery of hydrop ...... dsorption and biodistribution.
@en
Intravenous delivery of hydrop ...... dsorption and biodistribution.
@nl
type
label
Intravenous delivery of hydrop ...... dsorption and biodistribution.
@en
Intravenous delivery of hydrop ...... dsorption and biodistribution.
@nl
prefLabel
Intravenous delivery of hydrop ...... dsorption and biodistribution.
@en
Intravenous delivery of hydrop ...... dsorption and biodistribution.
@nl
P2093
P50
P356
P1476
Intravenous delivery of hydrop ...... dsorption and biodistribution.
@en
P2093
Jarno Salonen
Jussi Rytkönen
Markus Nyman
P304
P356
10.1021/MP200611D
P407
P50
P577
2012-02-01T00:00:00Z